HM Payson & Co’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-330
Closed -$27.4K 997
2023
Q1
$27.4K Sell
330
-100
-23% -$9.41K ﹤0.01% 667
2022
Q4
$44.2K Buy
430
+200
+87% +$23K ﹤0.01% 573
2022
Q3
$24K Hold
230
﹤0.01% 668
2022
Q2
$25K Hold
230
﹤0.01% 678
2022
Q1
$24K Hold
230
﹤0.01% 710
2021
Q4
$28K Hold
230
﹤0.01% 700
2021
Q3
$26K Hold
230
﹤0.01% 700
2021
Q2
$22K Hold
230
﹤0.01% 719
2021
Q1
$17K Hold
230
﹤0.01% 789
2020
Q4
$16K Hold
230
﹤0.01% 803
2020
Q3
$13K Hold
230
﹤0.01% 794
2020
Q2
$10K Hold
230
﹤0.01% 742
2020
Q1
$13K Hold
230
﹤0.01% 701
2019
Q4
$14K Hold
230
﹤0.01% 768
2019
Q3
$13K Buy
+230
New +$12.7K ﹤0.01% 778

Other funds holding AMN

HM Payson & Co's AMN Position: Q2 2023 in Review

HM Payson & Co sold out of AMN Healthcare (AMN) in Q2 2023, closing a stake of 330 shares — an estimated $27.4K sold.

HM Payson & Co first reported a position in AMN in Q3 2019 and held it in 15 quarters. The position peaked at $44.2K in Q4 2022. 425 funds tracked by Wall St. Rank hold AMN as of Q2 2023.

  • HM Payson & Co reported no remaining AMN Healthcare position as of Q2 2023 after selling out during the quarter.
  • HM Payson & Co sold 330 AMN Healthcare shares in Q2 2023, an estimated $27.4K.
  • HM Payson & Co first reported a position in AMN Healthcare in Q3 2019 and held it in 15 quarters.
  • HM Payson & Co's AMN Healthcare position peaked at $44.2K in Q4 2022.
  • 425 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2023.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.